{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:49Z","timestamp":1786119229646,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/aco.0b013e32831a43c7","type":"journal-article","created":{"date-parts":[[2009,2,20]],"date-time":"2009-02-20T04:14:13Z","timestamp":1235103253000},"page":"114-120","source":"Crossref","is-referenced-by-count":0,"title":["Ca2+: is there something new for the cardiovascular anesthesiologist?"],"prefix":"10.1097","volume":"22","author":[{"given":"James D","family":"Hannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe R","family":"Housmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210129","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.jacc.2006.08.039","article-title":"Emerging therapies for the management of decompensated heart failure: from bench to bedside","volume":"48","author":"deGoma","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R2-21-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ceca.2005.06.017","article-title":"The control of sarcoplasmic reticulum Ca content in cardiac muscle","volume":"38","author":"Diaz","year":"2005","journal-title":"Cell Calcium"},{"key":"R3-21-20210129","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.RES.87.4.275","article-title":"Calcium fluxes involved in control of cardiac myocyte contraction","volume":"87","author":"Bers","year":"2000","journal-title":"Circ Res"},{"key":"R4-21-20210129","first-page":"36","article-title":"Measurement of calcium transport in heart using modern approaches","volume":"4","author":"Bers","year":"1996","journal-title":"New Horiz"},{"key":"R5-21-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.RES.0000233386.02708.72","article-title":"Sarcoplasmic reticulum and nuclear envelope are one highly interconnected Ca2+ store throughout cardiac myocyte","volume":"99","author":"Wu","year":"2006","journal-title":"Circ Res"},{"key":"R6-21-20210129","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0500059102","article-title":"Ca2+ blinks: rapid nanoscopic store calcium signalling","volume":"102","author":"Brochet","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R7-21-20210129","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1529\/biophysj.108.130385","article-title":"Ca2+-mobility in the sarcoplasmic reticulum of ventricular myocytes is low","volume":"95","author":"Swietach","year":"2008","journal-title":"Biophys J"},{"key":"R8-21-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1196\/annals.1420.006","article-title":"The missing link in the mystery of normal automaticity of cardiac pacemaker cells","volume":"1123","author":"Lakatta","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R9-21-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1196\/annals.1420.024","article-title":"Control of cardiac rate by \u2018funny\u2019 channels in health and disease","volume":"1123","author":"Barbuti","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R10-21-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hlc.2007.07.005","article-title":"Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells","volume":"16","author":"Maltsev","year":"2007","journal-title":"Heart Lung Circ"},{"key":"R12-21-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/280235a0","article-title":"How does adrenaline accelerate the heart?","volume":"280","author":"Brown","year":"1979","journal-title":"Nature"},{"key":"R13-21-20210129","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/cvr\/cvm058","article-title":"Dynamic interactions of an intracellular Ca2+ clock and membrane ion channel clock underlie robust initiation and regulation of cardiac pacemaker function","volume":"77","author":"Maltsev","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R14-21-20210129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1126\/science.8235594","article-title":"Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle","volume":"262","author":"Cheng","year":"1993","journal-title":"Science"},{"key":"R15-21-20210129","first-page":"101","article-title":"Intracellular Ca2+ release sparks atrial pacemaker activity","volume":"16","author":"Lipsius","year":"2001","journal-title":"News Physiol Sci"},{"key":"R16-21-20210129","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","article-title":"Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure","volume":"109","author":"Mulder","year":"2004","journal-title":"Circulation"},{"key":"R17-21-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000108387","article-title":"Long-term safety and efficacy of ivabradine in patients with chronic stable angina","volume":"108","author":"Lopez-Bescos","year":"2007","journal-title":"Cardiology"},{"key":"R18-21-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000112412","article-title":"The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: baseline characteristics of the study population","volume":"110","author":"Ferrari","year":"2008","journal-title":"Cardiology"},{"key":"R19-21-20210129","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"R21-21-20210129","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"R22-21-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjp.2008.168","article-title":"Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function","volume":"154","author":"Triggle","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R23-21-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","article-title":"Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice","volume":"154","author":"Drouin","year":"2008","journal-title":"Br J Pharmacol"},{"key":"R24-21-20210129","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1161\/CIRCULATIONAHA.106.616011","article-title":"New insights into pacemaker activity: promoting understanding of sick sinus syndrome","volume":"115","author":"Dobrzynski","year":"2007","journal-title":"Circulation"},{"key":"R25-21-20210129","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa052475","article-title":"Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel","volume":"354","author":"Milanesi","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-21-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.107.706887","article-title":"Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia","volume":"116","author":"Nof","year":"2007","journal-title":"Circulation"},{"key":"R27-21-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.yjmcc.2005.02.024","article-title":"A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families","volume":"38","author":"Smits","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"R28-21-20210129","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejheart.2007.01.011","article-title":"Alteration of myocardial sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger expression in human left ventricular volume overload","volume":"9","author":"Leszek","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R29-21-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1253\/circj.72.509","article-title":"Ryanodine receptor as a new therapeutic target of heart failure and lethal arrhythmia","volume":"72","author":"Yano","year":"2008","journal-title":"Circ J"},{"key":"R30-21-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cvr\/cvm009","article-title":"The sarcoplasmic reticulum and arrhythmogenic calcium release","volume":"77","author":"Venetucci","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R31-21-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.coph.2006.09.010","article-title":"Novel targets for treating heart and muscle disease: stabilizing ryanodine receptors and preventing intracellular calcium leak","volume":"7","author":"Lehnart","year":"2007","journal-title":"Curr Opin Pharmacol"},{"key":"R32-21-20210129","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.CIR.100.23.2308","article-title":"Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a","volume":"100","author":"del Monte","year":"1999","journal-title":"Circulation"},{"key":"R33-21-20210129","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/01.CCM.0000296273.72952.39","article-title":"Inotropes in the management of acute heart failure","volume":"36","author":"Petersen","year":"2008","journal-title":"Crit Care Med"},{"key":"R34-21-20210129","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/jmcc.2001.1368","article-title":"SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes","volume":"33","author":"Davia","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"R35-21-20210129","doi-asserted-by":"crossref","first-page":"H2356","DOI":"10.1152\/ajpheart.01310.2006","article-title":"Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts","volume":"292","author":"Sakata","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R36-21-20210129","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/mt.2008.61","article-title":"Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats","volume":"16","author":"Niwano","year":"2008","journal-title":"Mol Ther"},{"key":"R37-21-20210129","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","article-title":"Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a preclinical model of heart failure","volume":"51","author":"Kawase","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R38-21-20210129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/mt.2008.89","article-title":"SERCA2a gene therapy for heart failure: ready for primetime?","volume":"16","author":"Periasamy","year":"2008","journal-title":"Mol Ther"},{"key":"R39-21-20210129","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ejheart.2008.07.006","article-title":"Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.","volume":"10","author":"Coletta","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"R40-21-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejheart.2008.01.002","article-title":"Overview of emerging pharmacologic agents for acute heart failure syndromes","volume":"10","author":"De Luca","year":"2008","journal-title":"Eur J Heart Fail"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACO.0b013e32831a43c7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:33Z","timestamp":1786038213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001503-200902000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e32831a43c7","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}